Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15984012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Amyloid-beta (Abeta) peptide levels are widely measured by enzyme-linked immunosorbent assay (ELISA) in Alzheimer's disease research. Here, we show that oligomerization of Abeta results in underestimated Abeta ELISA levels. The implications are that comprehensive analysis of soluble Abeta requires either sample pretreatment at denaturing conditions or novel conformation-dependent immunoassays. Our findings might be of relevance for many neurodegenerative disorders in which soluble protein aggregates are the main neurotoxic species.
Medical subject headings
- Amyloid beta-Peptides
- Enzyme-Linked Immunosorbent Assay